All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

AstraZeneca PLC revenue reports

AstraZeneca PLC financial reports, AstraZeneca PLC annual revenue in 2024. When does AstraZeneca PLC report revenue?
Add to widgets
Added to widgets

AstraZeneca PLC total revenue, net income and dynamics of changes in Euro today

AstraZeneca PLC current income in Euro. Net income of AstraZeneca PLC today amounted to 550 000 000 €. These are the main financial indicators of AstraZeneca PLC. AstraZeneca PLC online financial report chart. The financial report chart on our website displays information by dates from 31/03/2019 to 30/06/2021. The value of AstraZeneca PLC assets on the online chart is displayed in green bars.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
30/06/2021 7 677 184 080 € +41.16 % ↑ 513 680 200 € +323.08 % ↑
31/03/2021 6 836 616 480 € +33.31 % ↑ 1 457 917 804 € +163.24 % ↑
31/12/2020 6 920 673 240 € +11.19 % ↑ 945 171 568 € +223.32 % ↑
30/09/2020 6 143 615 192 € +2.68 % ↑ 605 208 672 € +116.72 % ↑
31/12/2019 6 223 936 096 € - 292 330 732 € -
30/09/2019 5 982 973 384 € - 279 255 236 € -
30/06/2019 5 438 472 372 € - 121 415 320 € -
31/03/2019 5 128 396 324 € - 553 840 652 € -
Show:
to

AstraZeneca PLC financial report charts

The latest dates of AstraZeneca PLC financial statements available online: 31/03/2019, 31/03/2021, 30/06/2021. The dates of the financial statements are determined by the accounting rules. The current date of the financial report of AstraZeneca PLC for today is 30/06/2021. Gross profit AstraZeneca PLC is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit AstraZeneca PLC is 6 035 000 000 €

AstraZeneca PLC quarterly report dates

Cost of revenue AstraZeneca PLC is the total cost of producing and distributing of products and services of a company. Cost of revenue AstraZeneca PLC is 2 185 000 000 € Total revenue AstraZeneca PLC refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue AstraZeneca PLC is 8 220 000 000 € Operating income AstraZeneca PLC is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income AstraZeneca PLC is 1 197 000 000 €

Net income AstraZeneca PLC is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income AstraZeneca PLC is 550 000 000 € Current assets AstraZeneca PLC is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets AstraZeneca PLC is 27 274 000 000 € Total assets AstraZeneca PLC refers to the total amount of assets owned by a person or entity. Total assets AstraZeneca PLC is 73 641 000 000 €

30/06/2021 31/03/2021 31/12/2020 30/09/2020 31/12/2019 30/09/2019 30/06/2019 31/03/2019
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
5 636 472 740 € 5 102 245 332 € 5 504 783 816 € 4 872 490 188 € 4 891 169 468 € 4 786 565 500 € 4 458 744 136 € 4 109 441 600 €
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
2 040 711 340 € 1 734 371 148 € 1 415 889 424 € 1 271 125 004 € 1 332 766 628 € 1 196 407 884 € 979 728 236 € 1 018 954 724 €
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
7 677 184 080 € 6 836 616 480 € 6 920 673 240 € 6 143 615 192 € 6 223 936 096 € 5 982 973 384 € 5 438 472 372 € 5 128 396 324 €
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - - - - -
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
1 117 954 908 € 1 091 803 916 € 509 944 344 € 1 197 341 848 € 1 092 737 880 € 838 699 672 € 793 869 400 € 1 120 756 800 €
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
513 680 200 € 1 457 917 804 € 945 171 568 € 605 208 672 € 292 330 732 € 279 255 236 € 121 415 320 € 553 840 652 €
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
1 690 474 840 € 1 587 738 800 € 1 756 786 284 € 1 383 200 684 € 1 366 389 332 € 1 240 304 192 € 1 238 436 264 € 1 150 643 648 €
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
6 559 229 172 € 5 744 812 564 € 6 410 728 896 € 4 946 273 344 € 5 131 198 216 € 5 144 273 712 € 4 644 602 972 € 4 007 639 524 €
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
25 472 934 136 € 17 497 815 540 € 18 253 392 416 € 16 966 390 024 € 14 535 281 732 € 12 627 193 280 € 14 213 998 116 € 12 747 674 636 €
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
68 778 042 924 € 60 638 546 664 € 62 322 483 756 € 59 878 299 968 € 57 323 908 428 € 55 016 083 384 € 57 802 097 996 € 57 023 172 020 €
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
14 539 017 588 € 7 131 749 104 € 7 314 806 048 € 7 538 957 408 € 5 014 452 716 € 3 705 035 188 € 5 069 556 592 € 3 862 875 104 €
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 16 920 625 788 € 13 800 252 064 € 14 975 178 776 € 17 050 446 784 €
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - -
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 43 691 769 884 € 42 249 729 468 € 43 726 326 552 € 45 788 519 064 €
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 76.22 % 76.80 % 75.65 % 80.30 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
14 640 819 664 € 13 477 100 520 € 14 590 385 608 € 11 389 690 980 € 12 260 145 428 € 11 360 738 096 € 12 653 344 272 € 9 790 744 612 €
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - 1 284 200 500 € 1 030 162 292 € 820 020 392 € -361 444 068 €

Last revenue report of AstraZeneca PLC was 30/06/2021. According to last financial report total revenue in AstraZeneca PLC was 7 677 184 080 Euro and changed by +41.16% since last year. Net income in AstraZeneca PLC was 513 680 200 € in last quartal, net income changes to +323.08%.

Current cash AstraZeneca PLC - the sum of all of the cash a company has on the date of report. Current cash AstraZeneca PLC is 15 567 000 000 €

AstraZeneca PLC stocks data

AstraZeneca PLC financials